CRC
BIOA

Curi RMB Capital’s BioAmber Inc. BIOA Stock Holding History

Curi RMB Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,500
Closed -$40K – 794
2017
Q2 		$40K Sell
15,500
-300
-2% -$689 ﹤0.01% 711
2017
Q1 		$37K Buy
+15,800
New +$60.1K ﹤0.01% 545

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Curi RMB Capital's BIOA Position: Q3 2017 in Review

Curi RMB Capital sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 15,500 shares — an estimated $40K sold.

Curi RMB Capital first reported a position in BIOA in Q1 2017 and held it in 2 quarters. The position peaked at $40K in Q2 2017. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Curi RMB Capital reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Curi RMB Capital sold 15,500 BioAmber Inc. shares in Q3 2017, an estimated $40K.
  • Curi RMB Capital first reported a position in BioAmber Inc. in Q1 2017 and held it in 2 quarters.
  • Curi RMB Capital's BioAmber Inc. position peaked at $40K in Q2 2017.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Curi RMB Capital's 13F filing for Q3 2017, filed 14 Nov 2017.